📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 8 points (worsening)
💹 Market Data
Market Cap$5.63B
Shares Outstanding60.88M
Float56.89M
Cash$1.00B
Debt$2.04B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 2.7% shares (2025Q4 vs prior)
359 institutional holders · 61.13M shares
#1
T. Rowe Price Investment Management, Inc.
11.79M shares
#2
PRICE T ROWE ASSOCIATES INC /MD/
5.85M shares
#3
VANGUARD GROUP INC
5.41M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.62M
Days to Cover3.9
% of Float4.6%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
3
FORM3
Apr 07, 2026
4
INSIDER TRANSACTION
Apr 07, 2026
4
INSIDER TRANSACTION
Apr 01, 2026
4
INSIDER TRANSACTION
Apr 01, 2026
4
INSIDER TRANSACTION
Apr 01, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ESAB
📊 ESAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ESAB Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.